DNA Methylation Could Predict Ovarian, Breast Cancers

A pair of new studies finds that analyzing material from a Pap smear can reveal tumor risk in distant parts of the body, potentially allowing early interventions.

smiling woman with curly hair and glasses
| 5 min read
health care provider standing in front of gynecology stirrups holding swabs for Pap smear
Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Malignancies that affect internal reproductive organs are a leading cause of global cancer incidence worldwide. Breast, cervical, ovarian, and uterine tumors account for more than half of cancers in women. However, cervical cancer is the only one of these cancer types with a reliable screening system. Routine Pap smears offer a simple, non-invasive way to detect precancerous cells and have reduced the incidence and mortality from cervical cancer by more than 50 percent.

New findings published in Nature Communications last week (February 1) suggest that a version of the Pap smear could be used to provide early warning of some other cancer types as well. In two studies, a group of researchers tested the ability of a new scoring system that the authors call WID-index, or women’s cancer risk identification index, based on the DNA methylation footprint in cervical samples, to predict the risk of developing ovarian and breast cancer.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • smiling woman with curly hair and glasses

    Anna Napolitano, PhD

    Anna Napolitano is a freelance science writer based in London with bylines in several outlets. As a PhD student and as a postdoc, she published several peer-reviewed papers in the immunology field.
Share
Image of a woman in a microbiology lab whose hair is caught on fire from a Bunsen burner.
April 1, 2025, Issue 1

Bunsen Burners and Bad Hair Days

Lab safety rules dictate that one must tie back long hair. Rosemarie Hansen learned the hard way when an open flame turned her locks into a lesson.

View this Issue
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Faster Fluid Measurements for Formulation Development

Meet Honeybun and Breeze Through Viscometry in Formulation Development

Unchained Labs
Conceptual image of biochemical laboratory sample preparation showing glassware and chemical formulas in the foreground and a scientist holding a pipette in the background.

Taking the Guesswork Out of Quality Control Standards

sartorius logo
An illustration of PFAS bubbles in front of a blue sky with clouds.

PFAS: The Forever Chemicals

sartorius logo

Products

Metrion Biosciences Logo

Metrion Biosciences launches NaV1.9 high-throughput screening assay to strengthen screening portfolio and advance research on new medicines for pain

Biotium Logo

Biotium Unveils New Assay Kit with Exceptional RNase Detection Sensitivity

Atelerix

Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China

Green Cooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Thermo Fisher Logo